FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Bianco says ‘Democrat policy is indefensible’ as GOP candidates top California governor polling

Pima County sheriff warns in NBC interview DNA tech issues in Nancy Guthrie case may take ‘months’ to resolve

Newsom weighs in on social media age restrictions, citing experience as a parent: ‘We need help’

FBI investigates criminal damage to federal ICE warehouse facility in Arizona

Hours After Publicly Appearing With Newsom, CA High Speed Rail Chief Arrested on Suspicion of Spousal Battery

Trump pulls endorsement from GOP lawmaker over alleged lack of support for administration’s tariff agenda

Is a Donald J. Trump Airport on Its Way? Big Move from Trump Family Suggests It’s Coming

The Sting: How a DEA Supervisor Was Caught Getting Non-Americans Into the Country as Fake Law Enforcement Assets, According to Court Docs

Nancy Guthrie disappearance fuels rise of ‘mom detectives’ swapping tips and losing sleep

Colombian nationals allegedly ran fake law firm, impersonated federal judges to defraud migrants out of $100K

Mamdani promotes NYC where ‘every family can afford a home,’ rips ICE’s ‘cruelty’ amid budget blowback

Trump reveals his ‘new hero’ Supreme Court justice after tariffs ruling

Trump raises global tariff to 15%

Trump torches ‘stupid’ AOC’s Munich showing, tees up fresh fight with progressive Democrats

Labor Dept deploys ‘strike team’ to California over $21B unemployment debt, fraud concerns

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”